This HTML5 document contains 61 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n10http://dx.doi.org/10.1158/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q92858515
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel article scientifique publié en 2020 գիտական հոդված հրատարակված 2020 թվականի հունվարի 22-ին artículu científicu espublizáu en xineru de 2020 scientific article published on 22 January 2020 наукова стаття, опублікована 22 січня 2020
p:P577
wds:Q92858515-19B0D471-16BC-4B01-B9E3-D20F69999EC6
wdt:P577
2020-01-22T00:00:00Z
p:P2093
wds:Q92858515-F21AC0DB-08AB-4D5C-B8A5-C2CA9CC57693 wds:Q92858515-BCB26DE4-A23F-4B87-9B95-67D90CC8F233 wds:Q92858515-BA5008B6-12B6-4AE6-A4A4-B1DA45EBB500 wds:Q92858515-E9E28EA2-8B6A-44BF-B39E-D47DA4930184 wds:Q92858515-E6949AA6-FBF6-4CF8-BC8E-C06FAC698549 wds:Q92858515-49FBC55E-9DD4-4825-BDB6-954B5DABE475 wds:Q92858515-4A1DABCE-C17C-4FF4-B2CF-1F58D6360A9F wds:Q92858515-91C25171-45A9-4834-B6ED-73AEC4C7B0A5 wds:Q92858515-7A3DA7F2-8156-4B59-8370-BF6C3551D71D wds:Q92858515-1AC5B879-D4A6-4F71-8EDD-D2217DBD32FA wds:Q92858515-040E5A5C-E40E-4807-96D3-99401C9C8A49 wds:Q92858515-0999BC7B-A3D5-4C46-820D-632EC7AAF4F8
wdt:P2093
Lisa C Holthof Marloes E C Broekmans Berris van Kessel Francois Gaudet Rengasamy Boominathan Jhon A Marin Soto Bhavesh Vaidya Christie P M Verkleij Jocelyn Sendecki Amy Axel Martijn W Heymans Kodandaram Pillarisetti
rdfs:label
Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab
skos:prefLabel
Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab
schema:name
Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab
p:P50
wds:Q92858515-7339F4E6-CE15-47E5-BCD5-D729DBC08910 wds:Q92858515-8F833273-7EC1-4F52-AF9E-E30597215C49 wds:Q92858515-AF834C0E-A737-4F82-96C2-2594A0291FF3 wds:Q92858515-F0AB5F47-FF3D-4AC7-8922-5E8AC76F454D wds:Q92858515-3438F06D-4D6F-427B-A4B3-9C13B1223D29
wdt:P50
wd:Q110172643 wd:Q92858510 wd:Q87712098 wd:Q92858507 wd:Q110173510
p:P1476
wds:Q92858515-D0437AFA-0F68-421C-BA43-B70839D732B3
wdt:P1476
Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab
p:P31
wds:Q92858515-FCF8806D-F460-4D82-8BBC-C7BE792278F6
wdt:P31
wd:Q13442814
p:P698
wds:Q92858515-CF836213-3344-4EAA-B967-0C9AA7A716BB
wdtn:P698
n12:31969333
wdt:P698
31969333
p:P1433
wds:Q92858515-1D5A85A7-855F-4C9D-862E-00DDEA693B69
wdt:P1433
wd:Q332253
p:P356
wds:Q92858515-F9E28BBB-37FB-4405-AFEC-5D360B26E01B
wdtn:P356
n10:1078-0432.CCR-19-2299
wdt:P356
10.1158/1078-0432.CCR-19-2299